[go: up one dir, main page]

AR055597A1 - Uso de sales de tiotripio en el tratamiento del asma persistente severa - Google Patents

Uso de sales de tiotripio en el tratamiento del asma persistente severa

Info

Publication number
AR055597A1
AR055597A1 ARP060103410A ARP060103410A AR055597A1 AR 055597 A1 AR055597 A1 AR 055597A1 AR P060103410 A ARP060103410 A AR P060103410A AR P060103410 A ARP060103410 A AR P060103410A AR 055597 A1 AR055597 A1 AR 055597A1
Authority
AR
Argentina
Prior art keywords
treatment
persistent asthma
severe persistent
salts
tiotripe
Prior art date
Application number
ARP060103410A
Other languages
English (en)
Inventor
Michael Engel
Stefan Heinrichs
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35432680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR055597(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR055597A1 publication Critical patent/AR055597A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente se refiere al uso de sales de tiotropio para la fabricacion de un medicamento para el tratamiento de pacientes que padecen asma persistente severa. Reivindicacion 1: Uso de sales de tiotropio (1) donde X denota un anion con una sola carga negativa, preferiblemente un anion que se selecciona entre cloruro, bromuro, yoduro, sulfato, fosfato, metanosulfonato, nitrato, maleato, acetato, citrato, fumarato, tartrato, oxalato, succinato, benzoato y p-toluenosulfonato, opcionalmente en forma de los hidratos y/o solvatos de los mismos, para la fabricacion de un medicamento para el tratamiento del asma persistente severa.
ARP060103410A 2005-08-06 2006-08-04 Uso de sales de tiotripio en el tratamiento del asma persistente severa AR055597A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05107266 2005-08-06

Publications (1)

Publication Number Publication Date
AR055597A1 true AR055597A1 (es) 2007-08-29

Family

ID=35432680

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103410A AR055597A1 (es) 2005-08-06 2006-08-04 Uso de sales de tiotripio en el tratamiento del asma persistente severa

Country Status (16)

Country Link
US (3) US20070032516A1 (es)
EP (1) EP1915158A1 (es)
JP (1) JP2009504604A (es)
KR (1) KR20080039974A (es)
CN (1) CN101237872A (es)
AR (1) AR055597A1 (es)
AU (1) AU2006277968A1 (es)
BR (1) BRPI0614394A2 (es)
CA (1) CA2617717C (es)
IL (1) IL189248A0 (es)
MX (1) MX2008001506A (es)
NZ (1) NZ566399A (es)
RU (1) RU2422144C2 (es)
TW (1) TWI409072B (es)
WO (1) WO2007017438A1 (es)
ZA (1) ZA200800186B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250426B2 (en) 2002-11-29 2007-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Tiotropium-containing pharmaceutical combination for inhalation
BRPI0620886A2 (pt) * 2006-01-04 2011-11-29 Boehringer Ingelheim Int uso de sais de tiotrópio no tratamento de asma persistente moderada
MX2012005711A (es) * 2009-11-17 2012-10-05 Cipla Ltd Soluciones de inhalacion.
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US5888396A (en) * 1996-12-17 1999-03-30 Perriello; Felix Anthony Bioremediation of pollutants with butane-utilizing bacteria
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
IL155335A0 (en) * 2000-10-12 2003-11-23 Boehringer Ingelheim Pharma Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
EP1511500A4 (en) * 2002-06-12 2009-04-29 Epigenesis Pharmaceuticals Llc COMBINATION OF ANTI-MUSCARINIC AGENTS AND NONGLUCOCORTICOID STEROIDS
US8962601B2 (en) * 2002-08-29 2015-02-24 Cipla Ltd Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
CA2608142A1 (en) * 2005-05-10 2006-11-16 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
WO2006123943A1 (en) * 2005-05-20 2006-11-23 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
BRPI0620886A2 (pt) 2006-01-04 2011-11-29 Boehringer Ingelheim Int uso de sais de tiotrópio no tratamento de asma persistente moderada

Also Published As

Publication number Publication date
US20070032516A1 (en) 2007-02-08
TW200744606A (en) 2007-12-16
NZ566399A (en) 2011-07-29
MX2008001506A (es) 2008-04-07
BRPI0614394A2 (pt) 2011-03-29
CA2617717A1 (en) 2007-02-15
CN101237872A (zh) 2008-08-06
CA2617717C (en) 2014-02-11
US20130245059A1 (en) 2013-09-19
JP2009504604A (ja) 2009-02-05
WO2007017438A1 (en) 2007-02-15
EP1915158A1 (en) 2008-04-30
KR20080039974A (ko) 2008-05-07
RU2008108302A (ru) 2009-09-20
US20090163531A1 (en) 2009-06-25
IL189248A0 (en) 2008-08-07
ZA200800186B (en) 2009-04-29
RU2422144C2 (ru) 2011-06-27
AU2006277968A1 (en) 2007-02-15
TWI409072B (zh) 2013-09-21

Similar Documents

Publication Publication Date Title
HRP20191617T1 (hr) Kombinacija koja sadrži inhibitor mek i inhibitor b-raf
AR072442A1 (es) Metodo para la terapia del cancer, uso, kit
AR046533A1 (es) Formulacion de aerosol destinada a la inhalacion, que contiene un agente anticolinergico
UY30440A1 (es) Nuevos compuestos
RU2011139107A (ru) Специфические соединения диарилгидантоина и диарилтиогидантоина
CO5540380A2 (es) Medicamentos inhalativos que contienen un nuevo anticolinergico en combinacion con corticosteroides y betamimeticos
JP2013526545A5 (es)
BRPI0608297A2 (pt) composições de lipossomos
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
BRPI0515103A (pt) composição farmacêutica, inalador, processos para preparar o mesmo, e uma composição farmacêutica, e, uso de uma composição farmacêutica
CO6170341A2 (es) Formulacion de aerosol que contiene derivados de benzoxazin-3onas
JP2015512943A5 (es)
MX2009010165A (es) Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704.
AR057099A1 (es) Una forma cristalina, un proceso de preparacion y composicion farmaceutica
AR039275A1 (es) Medicamento que contiene esteroides y un nuevo anticolinergico
SA519401614B1 (ar) مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
AR102640A1 (es) Composición para cuidado bucal que contiene sales de zinc y carbonato de calcio
CO6220856A2 (es) Formas cristalinas de un compuesto de 8-azabiciclo[3,2,1]octano
UA96304C2 (en) 2-METHYLMORPHOLINE PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
AR058082A1 (es) Formulacion en aerosol para la inhalacion de beta- agonistas
AR055597A1 (es) Uso de sales de tiotripio en el tratamiento del asma persistente severa
CO6150166A2 (es) Nuevos derivados de [1,3]tiazolo[4,5-d]pirimidin-2-(3h)-amina 5,7-disustituidos y su uso en terapia
AR059126A1 (es) Uso de sales de tiotropio en el tratamiento del asma persistente moderada
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
AR062476A1 (es) Beta - agonistas enentiomericamente puros, procedimientos para su preparacion y su uso como medicamentos

Legal Events

Date Code Title Description
FB Suspension of granting procedure